Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BJTRF · as of 2026-06-09
Financial statements
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.51B | $12.52B | $1.53B | $1.73B | $1.56B |
| Cost of Revenue | $0.59B | $0.55B | $0.48B | $0.64B | $0.44B |
| Gross Profit | $0.93B | $1.07B | $1.05B | $1.15B | $1.11B |
| Gross Margin %(computed) | 61.16% | 8.51% | 68.67% | 66.52% | 71.43% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.19B | $1.40B | $1.21B | $1.21B |
| Total Operating Expenses | $0.45B | $0.49B | $0.42B | $0.34B | $0.34B |
| Operating Income | $0.47B | $0.57B | $0.62B | $0.81B | $0.77B |
| Operating Margin %(computed) | 31.29% | 4.58% | 40.93% | 46.92% | 49.51% |
| Interest Income | $0.05B | $0.06B | $0.57B | $0.02B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.05B | $0.00B | $0.00B |
| Income Before Tax | $0.50B | $0.63B | $0.69B | $0.83B | $0.78B |
| Income Tax Expense | $0.09B | $0.10B | $0.10B | $0.13B | $0.13B |
| Net Income | $0.40B | $0.50B | $4.22B | $0.65B | $0.61B |
| Net Margin %(computed) | 26.25% | 3.99% | 276.71% | 37.31% | 39.06% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.47 | $4.66 | $0.65 | $0.77 | $0.73 |
| Wtd Avg Shares | 0.84B | 0.84B | 0.84B | 0.84B | 0.84B |
| EBITDA | $0.57B | $0.72B | $0.64B | $0.88B | $0.79B |
| EBITDA Margin %(computed) | 37.79% | 5.77% | 42.01% | 50.69% | 50.55% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · HKD · B
Explore more Beijing Tong Ren Tang Chinese Medicine Company Limited data
About Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Income Statement
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BJTRF reported revenue of $1.51B, gross profit of $0.93B (gross margin 61.16%), and net income of $0.40B — a net profit margin of 26.25%.
Frequently asked questions
BJTRF · 4 questionsBeijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) reported revenue of $1.51B for 2025, down 87.9% year-over-year.
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09